0000899243-17-019943.txt : 20170809 0000899243-17-019943.hdr.sgml : 20170809 20170809171625 ACCESSION NUMBER: 0000899243-17-019943 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170807 FILED AS OF DATE: 20170809 DATE AS OF CHANGE: 20170809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lambing Joseph CENTRAL INDEX KEY: 0001655816 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 171018879 MAIL ADDRESS: STREET 1: C/O MYOKARDIA, INC. STREET 2: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia Inc CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-07 0 0001552451 MyoKardia Inc MYOK 0001655816 Lambing Joseph C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Common Stock 2017-08-07 4 S 0 5000 25.00 D 119718 D Common Stock 2017-08-07 4 S 0 5000 30.00 D 114718 D Common Stock 2017-08-08 4 S 0 5000 35.00 D 109718 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Senior Vice President, Non-Clinical and Pharmaceutical Development /s/ Jake Bauer, as Attorney-in-Fact 2017-08-09